Literature DB >> 20187741

Serological evidence of human hantavirus infections in Guinea, West Africa.

Boris Klempa1, Lamine Koivogui, Oumar Sylla, Kekoura Koulemou, Brita Auste, Detlev H Krüger, Jan ter Meulen.   

Abstract

We recently discovered a novel hantavirus, Sangassou virus, in Guinea, West Africa. Using enzyme-linked immunosorbent assays followed by confirmatory and serotyping assays, we retrospectively detected hantavirus antibodies in 3 (4.4%) of 68 patients with fever of unknown origin in Sangassou village, Forest Guinea. A population-based survey in Forest Guinea (n = 649) found the prevalence of hantavirus antibodies to be 1.2%. Specific neutralizing antibodies against Sangassou virus were demonstrated in serum samples from 2 patients and in 2 serum samples of the serosurvey. Our data allow us to conclude that hantavirus infections may be a significant unrecognized medical problem in at least this part of Africa.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20187741     DOI: 10.1086/651169

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Sangassou virus, the first hantavirus isolate from Africa, displays genetic and functional properties distinct from those of other murinae-associated hantaviruses.

Authors:  Boris Klempa; Peter T Witkowski; Elena Popugaeva; Brita Auste; Lamine Koivogui; Elisabeth Fichet-Calvet; Thomas Strecker; Jan Ter Meulen; Detlev H Krüger
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  The diversity of human RNA viruses.

Authors:  Mark E J Woolhouse; Kyle Adair
Journal:  Future Virol       Date:  2013-02       Impact factor: 1.831

Review 3.  Human pathogenic hantaviruses and prevention of infection.

Authors:  Detlev H Krüger; Günther Schönrich; Boris Klempa
Journal:  Hum Vaccin       Date:  2011-06-01

Review 4.  Hantavirus infection: a global zoonotic challenge.

Authors:  Hong Jiang; Xuyang Zheng; Limei Wang; Hong Du; Pingzhong Wang; Xuefan Bai
Journal:  Virol Sin       Date:  2017-01-23       Impact factor: 4.327

5.  Hantavirus entry: Perspectives and recent advances.

Authors:  Eva Mittler; Maria Eugenia Dieterle; Lara M Kleinfelter; Megan M Slough; Kartik Chandran; Rohit K Jangra
Journal:  Adv Virus Res       Date:  2019-08-07       Impact factor: 9.937

Review 6.  Innate Immunity to Orthohantaviruses: Could Divergent Immune Interactions Explain Host-specific Disease Outcomes?

Authors:  Alison M Kell
Journal:  J Mol Biol       Date:  2021-09-04       Impact factor: 5.469

7.  Meeting report: Tenth International Conference on Hantaviruses.

Authors:  Anna Papa; Antti Vaheri; James W LeDuc; Detlev H Krüger; Tatjana Avšič-Županc; Jiro Arikawa; Jin-Won Song; Alemka Markotić; Jan Clement; Mifang Liang; Dexin Li; Liudmila N Yashina; Colleen B Jonsson; Connie S Schmaljohn
Journal:  Antiviral Res       Date:  2016-08-17       Impact factor: 5.970

8.  Detection of possible spillover of a novel hantavirus in a Natal mastomys from Guinea.

Authors:  Léonce Kouadio; Kathrin Nowak; Emmanuel Couacy-Hymann; Chantal Akoua-Koffi; Ariane Düx; Fee Zimmermann; Bernard K Allali; Laye Kourouma; Karim Bangoura; Sophie Koendgen; Peter T Witkowski; Detlev H Krüger; Sébastien Calvignac-Spencer; Fabian H Leendertz
Journal:  Virus Genes       Date:  2019-10-25       Impact factor: 2.332

9.  Prevalence of Orthohantavirus-Reactive Antibodies in Humans and Peri-Domestic Rodents in Northern Ethiopia.

Authors:  Yonas Meheretu; Åsa Granberg; Gebregiorgis Berhane; Hussein Khalil; Olivia Wesula Lwande; Mengistu Mitiku; Kiros Welegerima; Joëlle Goüy de Bellocq; Josef Bryja; Hagos Abreha; Herwig Leirs; Frauke Ecke; Magnus Evander
Journal:  Viruses       Date:  2021-06-02       Impact factor: 5.048

10.  High diversity of RNA viruses in rodents, Ethiopia.

Authors:  Yonas Meheretu; Dagmar Cížková; Jana Těšíková; Kiros Welegerima; Zewdneh Tomas; Dawit Kidane; Kokob Girmay; Jonas Schmidt-Chanasit; Josef Bryja; Stephan Günther; Anna Bryjová; Herwig Leirs; Joëlle Goüy de Bellocq
Journal:  Emerg Infect Dis       Date:  2012-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.